How to translate organ-chips to reduce the use of animals and accelerate therapeutic delivery
Format: 1-hour session
Date & Time: 27th April 2026, 1.30–2.30 PM UK / 8.30 – 9.30 am EST
Platform: Zoom
1.30 PM – Thought Leader Interview
Duration: 20 minutes
Title: How to translate organ-chips to reduce the use of animals and accelerate therapeutic delivery
Interview with: Professor Martin Knight, Professor of Mechanobiology, Queen Mary University of London
1.50 PM – Panel Discussion
Title: How to translate organ-chips to reduce the use of animals and accelerate therapeutic delivery
Duration: 30 minutes
Key Themes:
Where OoC delivers real value
- Which drug discovery decisions benefit most from OoC today?
- What level of standardisation is essential for adoption?
- Translating organ-chips to reduce the use of animals and accelerate therapeutic delivery
- Regulatory and future outlook
Moderator: Professor Martin Knight, Professor of Mechanobiology, Queen Mary University of London
Panellists:
- Prof Hazel Screen, Professor of Biomedical Engineering, Queen Mary University of London
- Helena Rannikmae, Scientific Leader, Translational In Vitro Models, GlaxoSmithKline
- Emily Richardson, Lead Scientist R&D, CN Bio
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox